Location History:
- Lianyungang, CN (2012)
- Jiangsu, CN (2012 - 2019)
Company Filing History:
2 out of 2 
1 out of 24 
1 out of 832,912 Years Active: 2012-2019
Title: Aifeng Lv: Innovator in Pharmaceutical Chemistry
Introduction
Aifeng Lv is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for treating various diseases. His work has led to the filing of multiple patents, showcasing his expertise and dedication to advancing medical science.
Latest Patents
Aifeng Lv holds 4 patents, with his latest inventions focusing on C-Met inhibitors and modified exendins. One of his recent patents discloses crystalline free bases and crystalline acid salts of C-Met inhibitors, along with their preparation methods and uses. This invention includes various crystal forms and methods for regulating the catalytic activity of protein kinases, which are crucial in treating protein kinase-related diseases. Another significant patent involves modified exendins that serve as GLP-1 receptor agonists, demonstrating higher stability compared to non-modified versions. These compounds are particularly useful in the treatment of type 2 diabetes.
Career Highlights
Throughout his career, Aifeng Lv has worked with Wuxi Grandchamp Pharmaceutical Technology Co., Ltd., where he has contributed to various research projects and innovations. His work in this company has been instrumental in advancing pharmaceutical technologies and developing new therapeutic agents.
Collaborations
Aifeng has collaborated with several professionals in his field, including Changan Sun and Yali Wang, who have contributed to his research endeavors. Their teamwork has fostered an environment of innovation and creativity, leading to the successful development of new pharmaceutical solutions.
Conclusion
Aifeng Lv's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to impact the development of treatments for critical health issues, showcasing the importance of innovation in medicine.